$VRTX
AI分析生成日 May 11, 2026
AI Score
Buy$VRTX
Vertex Pharmaceuticals
$VRTXNASDAQHealthcareLarge-Cap
Vertex discovers and develops medicines for cystic fibrosis and other serious diseases.
Market Cap
$105.0B
Revenue (TTM)
$10.3B
+12.0%
Net Income (TTM)
$3.8B
+15.0%
EPS (TTM)
$14.80
P/E Ratio
28.0
Dividend Yield
0.0%
52-Week Range
$350-$500
Beta
0.42
Dimension Scores
Fundamental
80Technical
72Sentiment
76Risk / Reward
78Momentum
74Financial Health
Profitability
85strong
Growth
77strong
Liquidity
86strong
Solvency
82strong
Efficiency
78strong
Valuation, technical analysis, investment thesis, risk assessment and more for $VRTX
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。